⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11224676 | 0.81 | ALOX15 (0.48) | — | |
| Hydrochloric Acid SCHEMBL11222556 | 0.79 | ALOX15 (0.47) | — | |
| SCHEMBL2908012 | 0.78 | — | — | |
| SCHEMBL2496039 | 0.78 | — | — | |
| SCHEMBL10586879 | 0.78 | ALOX15 (0.36) | — | |
| SCHEMBL1562428 | 0.77 | — | — | |
| SCHEMBL1562433 | 0.77 | — | — | |
| SCHEMBL1145782 | 0.77 | — | — | |
| SCHEMBL28025856 | 0.77 | — | — | |
| SCHEMBL10729050 | 0.77 | ALOX15 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2064209-A1 | PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY | AstraZeneca AB (SE) | 2009-06-03 | — | — | EP | claimed |
| WO-2008020222-A1 | PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY | ASTRAZENECA AB (SE) | 2008-02-21 | — | — | WO | claimed |
| EP-0193826-B1 | COLOUR-PHOTOGRAPHIC RECORDING MATERIAL PROVIDED WITH A SILVER HALIDE EMULSION, AND PROCESS FOR MAKING THE SAME | Agfa-Gevaert AG (DE) | 1991-03-13 | — | — | EP | claimed |
| US-4705747-A | Color photographic recording material containing a silver halide emulsion and a process for its production | AGFA GEVAERT AKTIENGESELLSCHAFT (DE) | 1987-11-10 | — | — | US | claimed |
| US-20250388541-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2024132767-A1 | PHOSPHOGLICERATE DEHYDROGENASE INHIBITORS FOR THE TREATMENT OF FIBROSIS | CHIESI FARMACEUTICI S.P.A. (IT) | 2024-06-27 | — | — | WO | disclosed |
| CN-118019742-A | Novel benzodiazepine derivatives as GABA Aγ1 PAM | 豪夫迈·罗氏有限公司 | 2024-05-10 | — | — | CN | disclosed |
| EP-3884939-B1 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | RAZE THERAPEUTICS INC (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230312536-A1 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | RAZE THERAPEUTICS, INC. | 2023-10-05 | — | — | US | disclosed |
| US-20230250080-A1 | ENZYME INHIBITORS | KALVISTA PHARMACEUTICALS LTD (GB) | 2023-08-10 | — | — | US | disclosed |
| WO-2023086383-A1 | SELECT KRAS G12C INHIBITORS AND USES THEREOF | 1200 PHARMA LLC (US) | 2023-05-19 | — | — | WO | disclosed |
| US-11613527-B2 | Enzyme inhibitors | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2023-03-28 | — | — | US | disclosed |
| EP-0688217-A4 | — | — | 1996-01-10 | — | — | EP | disclosed |
| EP-0688217-A1 | HETEROCYCLE-CONTAINING MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1995-12-27 | — | — | EP | disclosed |
| WO-1995023792-A1 | USE OF IMIDAZOLE DERIVATIVES FOR TREATING DISORDERS INVOLVING ANGIOTENSIN RECEPTORS AT1 AND AT2, CERTAIN SUCH PRODUCTS, PREPARATION THEREOF, USE THEREOF AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | ROUSSEL UCLAF (FR) | 1995-09-08 | — | — | WO | disclosed |
| WO-1995023791-A1 | NOVEL TETRASUBSTITUTED IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING NOVEL INTERMEDIATES, USE THEREOF AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | ROUSSEL UCLAF (FR) | 1995-09-08 | — | — | WO | disclosed |
| WO-1994021258-A1 | HETEROCYCLE-CONTAINING MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 1994-09-29 | — | — | WO | disclosed |
| EP-0324377-A2 | Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-07-19 | — | — | EP | disclosed |
| US-4672128-A | REACTING IMIDAZOLES WITH CARBON DIOXIDE AND AN ALKALI METAL CARBONATE, BICARBONATE, OR HYDROXIDE AT ELEVATED TEMPERATURE AND PRESSURE | BASF AKTIENGESELLSCHAFT (DE) | 1987-06-09 | — | — | US | disclosed |
| EP-0172407-A1 | Process for the preparation of imidazole-4(5)-monocarbonic acids, their salts or betains | BASF Aktiengesellschaft (DE) | 1986-02-26 | — | — | EP | disclosed |